GAD-7 Scoring

About the GAD-7

Despite only recently being developed in 2006, the GAD-7 is one of the most commonly use measures for anxiety. There are many other validated measures that exist to identify and monitor anxiety, including the Hamilton Anxiety Scale (HAM-A), Hospital Anxiety and Depression Scale (HADS), Covi Anxiety Scale, Clinical Anxiety Scale (CAS), State-Trait Anxiety Inventory (STAI), Generalized Anxiety Disorder Questionnaire-IV (GAD-Q-IV), and World Health Organization Composite International Diagnostic Interview Short-Form (CIDI-SF), among others.

The GAD-7 was developed based on the 9 symptom criteria for generalized anxiety in the DSM-IV in addition to to 9 questions

To create the measure, the authors identified an initial list of potential items that could compose the scale. They started with 9 items that each corresponded to symptom criteria for generalized anxiety disorders within the DSM-IV, plus 4 additional items based on a fulsome review of other existing anxiety scales. Their goal was to identify the items that were most effective at measuring anxiety symptoms and shorten the length of the measure, in order to reduce assessment burden on patients and increase completion rates, while ensuring strong reliability and procedural, construct, and diagnostic criterion validity.

In order to do so, they completed a criterion-standard study that compared GAD self-report scale diagnoses to independent diagnoses made by mental health professionals, as well as functional status measures, disability days, and health care use. There were two phases to this project, the first being to identify the scale items and determine cut off scores, and the second focused on testing its reliabiity. The final 7 items were chosen based on them having the highest correlation with the total 13-item scale score (Spitzer et al., 2006).

When scoring the GAD-7, the authors recommend using a cut off score of 10 which ensures a sensitivity of 89% and a specificity of 82% for generalized anxiety disorders, meaning a score of 10 or higher on the GAD-7 is a good indication of potential Generalized Anxiety Disorder diagnosis (Spitzer et al., 2006). The measure can also assist with detecting three other common anxiety disorders, including Panic Disorder (sensitivity 74%, specificity 81%), Social Anxiety Disorder (sensitivity 72%, specificity 80%), and Post-Traumatic Stress Disorder (sensitivity 66%, specificity 81%) (Spitzer et al., 2006).

Who is the GAD-7 Assessment for?

Review the list below to determine if this assessment should be used with your client. If you answer NO the below question, the GAD-7 is a good fit to use with your client.

1. Is your client under 14? If they are, please refer to the Child Depression & Anxiety (RCADS 25) measure.

Note: The GAD-7 has shown good sensitivity, specificity, reliability, and factorial, construct, and concurrent validity in many specific subgroups, including patients with chronic migraines (Seo and Park, 2015), drug and alcohol use challenges (Delgadillo et al., 2012), as well as elderly people (Wild et al., 2014), and pregnant women (Zhong et al., 2015). Seeing that it is short and easy to administer, it is also effective in multiple settings, such as remote health surveys, epidemiologic studies, primary care, and in-person settings (García-Campayo et al., 2012).

Administering the GAD-7

The GAD-7 asks respondents how often, during the last 2 weeks, they were bothered by each of the 7 items. Response options are “not at all,” “several days,” “more than half the days,” and “nearly every day,” each scored as 0, 1, 2, and 3.

Though this is a self-report measure, validity is not compromised if the therapist reads the questions to the client to help them complete it. The scale can be administered by non-clinical staff, but must be interpreted by a lisenced clinician. If administering the scale over the phone, it is important to ensure the client can recall and implement the response scale when scoring each item. While the scale (shown below) has intentionally developed to be easy to understand for clients, it may be beneficial to review the scale questions when first introduced and to revisit or check in on a clients’ interpretation of questions at regular intervals throughout their time in care.

Watch this video from Buckinghamshire Healthcare NHS Trust, filmed at Mandeville Hospital, to see an example of the assessment being administered verbally in session. Notice how the client is actively interpreting the questions and discussing how his answers may apply, while the provider is asking clarifying questions when necessary to ensure the most accurate responses. This is an important process to ensure the client has an appropriate interpretation of the question and can recall moving forward.

Video Credit: buckshospitals

Scoring the GAD-7

Anxiety severity is calculated by assigning scores of 0, 1, 2, and 3, to the response categories of “not at all”, “several days”, “more than half the days”, and “nearly every day”, respectively. The total GAD-7 score for the seven items can range from 0 to 21.

Though the authors recommend a cut-point of 10 for anxiety disorder screening, a recent a meta-analysis suggests using a cut-off of 8 in order to optimize sensitivity without compromising specificity (Plummer et al., 2016). A score of 8 or greater represents a reasonable cut-point for identifying probable cases of Generalized Anxiety Disorder; however, further diagnostic assessment is warranted to determine the presence and type of anxiety disorder. When using a cut-off of 8, the GAD-7 has a sensitivity of 92% and specificity of 76% for the diagnosis of Generalized Anxiety Disorder (Plummer et al., 2016).

Screening for other anxiety disorders with the GAD-7

As mentioned previously, though the GAD-7 was designed primarily as a screening and severity measure for Generalized Anxiety Disorder, it also has moderately good operating characteristics for three other common anxiety disorders, including Panic Disorder, Social Anxiety Disorder, and Post-Traumatic Stress Disorder (Kroenke et al., 2007).

Performance of GAD-7 as Screening Tool for Anxiety Disorders (Using GAD-7 Score Cut-off of ≥ 10)

If other mental health challenges are present, evidence shows that adding a more precise measure in response to clients’ unique challenges drives improved clinical outcomes throughout treatment. For example, if a client is struggling with anxiety but you suspect it might be linked to PTSD, it can be beneficial to add a PTSD specific measure as it will be more sensitive to the unique symptoms present in this condition.

Diagnosis

If considering a diagnosis for anxiety, you should hold a clinical interview to determine if symptoms and distress levels outlined in GAD-7 results are clinically significant. It is also important to rule out other explanations or existing conditions that may lead to the presenting anxiety symptoms, including substance use, medical conditions, bereavement, or anything other factors that may be impacting your client.

Applying GAD-7 Results in Session

Now that you've started using the GAD-7 in session with your client(s), it's important to use the information you're gathering to inform clinical discussions, treatment decisions and improve both therapeutic alliance and clinical outcomes. Here are a few ways you can incorporate the GAD-7 results throughout care:

Treatment Planning

The information gathered by this measure can support and enrich clinical conversations, in order to give you a more complete picture of your clients experience. In addition to using results to inform care discussions, decisions and treatment planning, GAD-7 scores can also be used to inform additional techniques, interventions, exercises and referrals to improve care, based on each item of the GAD-7 (developed byVISN 4 MIRECC). Explore the additional suggestions below that can be considered for clients experiencing challenges with any of the 7 items:

1. Feeling nervous, anxious or on edge:

• Diaphragmatic breathing
• Thought monitoring
• Challenging maladaptive thoughts/feelings

2. Not being able to stop or control worrying.

• Identifying maladaptive thoughts/ feelings
• Challenging maladaptive thoughts/feelings
• Relaxation techniques

3. Worrying too much about different things.

• Thought monitoring
• Solvable vs. Unsolvable worries
• Identify possible solutions

4. Trouble relaxing

• Diaphragmatic breathing
• Autogenic Relaxation
• Guided Imagery

5. Being so restless that it is hard to sit still

• Diaphragmatic breathing
• Progressive Muscle Relaxation
• Guided imagery

6. Becoming easily annoyed or irritable

• Challenging maladaptive thoughts/feelings
• Breathing techniques
• Identify consequences to actions

7. Feeling afraid as if something awful might happen

• Thought monitoring
• Solvable vs. Unsolvable worries
• Challenging maladaptive thoughts/feelings

Monitoring Progress and Change

Using the GAD-7 throughout care helps both you and your client monitor progress in treatment and serves as an indicator of when things may not be improving. If a client scores less than 5 on 2 or more assessments in a row (with a minimum of 2 weeks between each assessment), there is good reason to believe that your client may be ready to discharge or transition into maintenance treatment.

References

What is the GAD-7?

The Generalized Anxiety Disorder-7 (GAD-7) is a brief, validated self-report questionnaire used to screen for and measure the severity of generalized anxiety disorder (GAD). Developed by Drs. Robert L. Spitzer, Kurt Kroenke, Janet B.W. Williams, and Bernd Löwe, the GAD-7 has become one of the most widely used anxiety screening tools in clinical practice and research.

The GAD-7 asks patients to rate how often they've been bothered by seven core anxiety symptoms over the past two weeks, including feeling nervous, inability to stop worrying, excessive worry, restlessness, difficulty relaxing, irritability, and feeling afraid. These items align with DSM-5-TR criteria for generalized anxiety disorder.

Each item is scored from 0 (not at all) to 3 (nearly every day), yielding a total score range of 0-21. Research has demonstrated that the GAD-7 has excellent internal consistency and good test-retest reliability. It's also shown validity for screening panic disorder, social anxiety disorder, and post-traumatic stress disorder, making it a versatile tool in mental health assessment.

GAD-7 Beyond Generalized Anxiety

While designed for GAD, research supports using the GAD-7 to screen for panic disorder, social anxiety disorder, and PTSD. A score ≥8 suggests probable anxiety disorder across these conditions.

Self-Report Format

Patients independently rate how often anxiety symptoms have bothered them over the past 2 weeks. Available in paper or digital format for convenient administration.

Quick Administration

Takes 2-5 minutes to complete. Scoring is straightforward, sum the seven items for a total score between 0 and 21.

Regular Monitoring

Administer at baseline and periodically throughout treatment (typically every 2-4 weeks) to track symptom progression and treatment effectiveness. Explore our platform features for automated tracking.

Optional Follow-Up Questions

The GAD-7 includes two additional questions about functional impairment and difficulty rating, providing context for score interpretation.

Administration Best Practices

GAD-7 Psychometric Properties

Frequently Asked Questions

What does GAD-7 stand for?

GAD-7 stands for Generalized Anxiety Disorder-7. It is a 7-item self-report questionnaire used to screen for and measure the severity of generalized anxiety disorder.

How long does the GAD-7 take to complete?

The GAD-7 typically takes 2-5 minutes for patients to complete. Scoring is automated, simply sum the seven items to get a total score from 0-21.

What is a normal GAD-7 score?

Scores of 0-4 are considered minimal anxiety. Scores of 5-9 indicate mild anxiety, 10-14 moderate, and 15-21 severe anxiety. A score of 10 or higher suggests a probable anxiety disorder requiring further evaluation.

What does a GAD-7 score of 10 mean?

A score of 10 is the cutoff for moderate anxiety. Scores of 10 or greater have 89% sensitivity and 82% specificity for generalized anxiety disorder. This level typically indicates the need for treatment (therapy, medication, or both).

How do you score the GAD-7?

Each of the 7 items is scored from 0 (not at all) to 3 (nearly every day). Add up all seven items to get a total score ranging from 0-21. Higher scores indicate greater anxiety severity.

Can the GAD-7 detect other anxiety disorders besides GAD?

Yes. Research shows that the GAD-7 is effective at screening for panic disorder, social anxiety disorder, and PTSD in addition to generalized anxiety disorder. A score ≥8 suggests probable anxiety disorder across these conditions.

Can the GAD-7 diagnose anxiety disorders?

No, the GAD-7 is a screening and monitoring tool, not a diagnostic tool. While it has good sensitivity and specificity for anxiety disorders, a full clinical evaluation is required to make a full clinical evaluation.

How often should the GAD-7 be administered?

For treatment monitoring, the GAD-7 is typically administered every 2-4 weeks. Regular administration allows clinicians to track symptom changes and assess treatment effectiveness over time.

What is a clinically significant change on the GAD-7?

A change of 4 points or more is considered clinically significant. For example, a decrease from 15 to 11 would indicate meaningful improvement in anxiety symptoms.

Can HiBoop automatically score the GAD-7?

Yes. HiBoop provides automated scoring of the GAD-7, severity classification, longitudinal trend visualization, and clinical alerts for severe scores. Clinicians see results without manual calculation.

Is the GAD-7 free to use?

Yes, the GAD-7 is free and in the public domain. It can be reproduced and used without permission or cost, making it one of the most accessible anxiety screening tools available.

Should I use GAD-7 with PHQ-9?

Yes, combining GAD-7 and PHQ-9 is best practice. Depression and anxiety frequently co-occur, and screening for both provides a more complete picture of a patient's mental health. Many clinics administer both assessments routinely. See the PHQ-9 vs GAD-7 vs PCL-5 comparison (/phq9-gad7-pcl5-comparison/) for a detailed side-by-side breakdown of when to use each tool.

What are the GAD-7 questionnaire questions?

The GAD-7 questionnaire consists of 7 questions asking how often you have been bothered by these problems over the past two weeks: (1) Feeling nervous, anxious, or on edge; (2) Not being able to stop or control worrying; (3) Worrying too much about different things; (4) Trouble relaxing; (5) Being so restless that it is hard to sit still; (6) Becoming easily annoyed or irritable; (7) Feeling afraid as if something awful might happen. Each question is scored 0 (Not at all), 1 (Several days), 2 (More than half the days), or 3 (Nearly every day). Total scores range from 0–21. The GAD-7 questionnaire is free to use and in the public domain.

What does a GAD-7 score of 5 mean?

A GAD-7 score of 5 falls in the mild anxiety range (5–9). This indicates some anxiety symptoms but does not typically meet criteria for a clinical anxiety disorder. Recommended action: psychoeducation about anxiety management, lifestyle modifications (sleep, exercise, caffeine reduction), and re-screen in 2–4 weeks. If symptoms persist or worsen, further evaluation is warranted.

What does a GAD-7 score of 8 mean?

A GAD-7 score of 8 is near the top of the mild anxiety range and approaches the moderate threshold. Research shows that a score ≥8 suggests probable anxiety disorder across multiple conditions, including panic disorder, social anxiety disorder, and PTSD, not just generalized anxiety. At this score, further evaluation for an anxiety disorder is recommended, particularly if symptoms are causing functional impairment.

What does a GAD-7 score of 15 mean?

A GAD-7 score of 15 falls in the severe anxiety range (15–21). This indicates significant anxiety symptom burden affecting daily functioning. Active treatment is warranted: a combination of cognitive-behavioral therapy (CBT) and/or medication (SSRIs/SNRIs) is typically recommended. Referral to a mental health specialist should be considered, particularly if symptoms have been present for more than 6 months.

What is a GAD-7 test?

A GAD-7 test is a standardized anxiety screening questionnaire consisting of 7 items aligned with DSM-5-TR criteria for generalized anxiety disorder. Clinicians and researchers use the term interchangeably with 'GAD-7 questionnaire' or 'GAD-7 assessment.' The test takes about 2–3 minutes to complete and produces a score from 0–21. It has 89% sensitivity and 82% specificity for GAD and is also effective for detecting panic disorder, social anxiety disorder, and PTSD.

How do I interpret a GAD-7 test score?

GAD-7 test scores are interpreted in four severity bands: 0–4 indicates minimal anxiety (no action typically needed); 5–9 indicates mild anxiety (watchful waiting and self-care); 10–14 indicates moderate anxiety (treatment plan recommended, consider therapy or medication); 15–21 indicates severe anxiety (active treatment warranted, immediate evaluation recommended). A GAD-7 score ≥10 has 89% sensitivity and 82% specificity for generalized anxiety disorder.

Additional Context

The Generalized Anxiety Disorder-7 (GAD-7) is a validated, 7-item self-report questionnaire that measures anxiety severity. Widely used for screening and monitoring treatment response as part of measurement-based care for generalized anxiety disorder.

The Generalized Anxiety Disorder-7 (GAD-7) is a brief, validated self-report questionnaire used to screen for and measure the severity of generalized anxiety disorder (GAD). Developed by Drs. Robert L. Spitzer, Kurt Kroenke, Janet B.W. Williams, and Bernd Löwe, the GAD-7 has become one of the most widely used anxiety screening tools in clinical practice and research.

The GAD-7 asks patients to rate how often they've been bothered by seven core anxiety symptoms over the past two weeks, including feeling nervous, inability to stop worrying, excessive worry, restlessness, difficulty relaxing, irritability, and feeling afraid. These items align with DSM-5-TR criteria for generalized anxiety disorder.

Each item is scored from 0 (not at all) to 3 (nearly every day), yielding a total score range of 0-21. Research has demonstrated that the GAD-7 has excellent internal consistency and good test-retest reliability. It's also shown validity for screening panic disorder, social anxiety disorder, and post-traumatic stress disorder, making it a versatile tool in mental health assessment.

While designed for GAD, research supports using the GAD-7 to screen for panic disorder, social anxiety disorder, and PTSD. A score ≥8 suggests probable anxiety disorder across these conditions.

How to Administer the GAD-7

Patients independently rate how often anxiety symptoms have bothered them over the past 2 weeks. Available in paper or digital format for convenient administration.

Takes 2-5 minutes to complete. Scoring is straightforward, sum the seven items for a total score between 0 and 21.

Administer at baseline and periodically throughout treatment (typically every 2-4 weeks) to track symptom progression and treatment effectiveness. Explore our platform features for automated tracking.

The GAD-7 includes two additional questions about functional impairment and difficulty rating, providing context for score interpretation.

• Clarify the past 2 weeks timeframe before patients begin
• Review responses with patients to understand context and symptom patterns
• Combine scores with clinical assessment, the GAD-7 is a screening tool, not a diagnostic substitute
• Consider co-administering with PHQ-9 to screen for depression and anxiety concurrently, see the PHQ-9 vs GAD-7 vs PCL-5 comparison
• Available in multiple validated translations for diverse patient populations

GAD-7 Scoring & Interpretation

Screening Cutoff Scores

Generalized Anxiety Disorder

Panic Disorder

Social Anxiety Disorder

Monitoring Treatment Response

A change of 4 points or more is considered clinically significant. Track scores over time to evaluate whether interventions are reducing anxiety symptoms.

If anxiety scores remain elevated after 6-8 weeks of treatment, consider adjusting medication dosage, changing therapeutic approach, or consulting with a specialist.

Validity

• 89% sensitivity for GAD at cutoff ≥10
• 82% specificity for GAD at cutoff ≥10
• ≥8 suggests probable panic disorder, social anxiety disorder, or PTSD
• AUC 0.906 for GAD diagnosis (Spitzer et al., 2006)

Reliability

• α = 0.92 Cronbach's alpha (excellent internal consistency)
• r = 0.83 test-retest intraclass correlation
• ≥4 pts clinically significant change threshold
• 13+ validated age range (adolescents to older adults)

Population Context

Documenting GAD-7 scores in clinical notes?

GAD-7 scores belong in the Objective section alongside PHQ-9 when both are administered. See our SOAP notes guide and therapy progress notes guide for templates and examples.